CRGX.Cargo Therapeutics, INC

Form 4: CARGO Therapeutics Executive Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report

📋All filings for Cargo Therapeutics, INC
🔒Login to Follow

Anup Radhakrishnan, Interim CEO, CFO, and COO of CARGO Therapeutics, Inc., sold 1,632 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

  • Anup Radhakrishnan, who serves as Interim Chief Executive Officer, Chief Financial Officer, and Chief Operating Officer of CARGO Therapeutics, Inc. (CRGX), reported a transaction involving the company's common stock.
  • On July 2, 2025, Radhakrishnan disposed of 1,632 shares of common stock at a price of $4.18 per share.
  • The sale was executed specifically to cover tax withholding obligations associated with the vesting of restricted stock units.
  • Following this transaction, Anup Radhakrishnan beneficially owns 120,781 shares of CARGO Therapeutics, Inc. common stock.

Sentiment

Score: 5

Explanation: Neutral. This is a routine, non-discretionary transaction for tax purposes, which is common for executives receiving equity compensation. It does not reflect a change in confidence or company performance.

Positives

  • The transaction represents a routine, non-discretionary sale of shares to cover tax withholding obligations, which is a standard practice for executives receiving equity compensation and does not indicate a lack of confidence in the company.

Negatives

  • The sale of shares is a routine transaction for tax purposes and does not reflect a negative outlook on the company's performance or future prospects.

Future Outlook

N/A

Management Comments

  • The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Industry Context

N/A

Stakeholder Impact

  • Minimal impact on shareholders as the sale of shares is a routine, non-discretionary transaction to cover tax obligations related to executive equity compensation.

Key Dates

DateDescription
07/02/2025Date of transaction for the common stock sale by Anup Radhakrishnan.
07/03/2025Signature date of the reporting person's attorney-in-fact on the Form 4 filing.

Recommendation

hold

Keywords

CARGO Therapeutics, CRGX, Form 4, insider transaction, stock sale, executive compensation, restricted stock units, tax withholding, Anup Radhakrishnan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.